Philip Morris cuts ZYN's price per pouch and guides US profit to about zero

Philip Morris International reported what it called a record quarterly high for operating income in the September 2026 quarter. Its adjusted operating margin, which leaves out items the company treats as outside normal trading, widened to 44.7% from 43.1% a year earlier. Even so, the company kept its target of 7% to 9% organic growth in operating income for the year, and said the result is now more likely to land in the middle or lower half of that range. The company blamed geopolitical costs and its step-up in US spending; the CFO said the US investment was being almost absorbed by the rest of the business. That spending is concentrated in the US, its smallest segment by revenue, where it sells ZYN nicotine pouches.

There, the company is cutting what it collects per pouch. Most of ZYN's flagship range is moving to 20-pouch cans from 15-pouch cans, with support programmes to clear the old cans from shelves. Massimo Andolina, the chief financial officer, said the bigger can means about 25% less revenue per pouch, all else equal, and in answer to an analyst described it plainly as a price cut on each pouch. The company says the change is meant to optimise ZYN's price premium in a fast-moving category. For the fourth quarter, Andolina guided US adjusted operating companies income, the company's measure of segment profit, to "around 0 or slightly negative".

The move goes further than the line management took a year ago. On the October 2025 call, explaining a return to a more normal level of promotions, it said it wanted to narrow ZYN's price gap with rivals rather than close it, while keeping ZYN a premium brand. By July 2026 it was naming a high price premium, alongside gaps in its range of stronger products, as a cause of weaker market share, and had begun addressing both, launching new variants, including ZYN Ultra at a lower price per pouch than the flagship range. The bigger can now takes the price cut to the flagship range itself.

Last quarter's US results show how little profit the segment was already making from its growth. Revenue rose sharply, driven by higher volume and by favourable price comparisons with promotions run a year earlier. Adjusted OCI rose only 1.5% on an organic basis, to $171 million, as marketing spending began to climb, and over nine months it was well below the prior year on the same basis.

The company does not plan to pull spending back to protect that profit. Andolina put US segment selling, general and administrative costs at around $370 million last quarter and said they would rise again in the fourth, as the company steps up investment behind the brand. Beyond that, he said the third-quarter level was enough to support ZYN, and told an analyst it was a good proxy for commercial investment over next year. He added that the lower price would weigh on revenue for about three quarters, while volume grows. On those terms, US profit next year depends mainly on how much extra volume the cheaper pouch wins, with costs held near today's level.

That is a large change for the segment and a modest one for the group. Calculated from the reported figures, the US supplied 7.4% of group net revenue last quarter and 3.3% of adjusted operating income. Andolina said organic OCI outside the US grew around 11% both in the quarter and year to date. The company's stated reasons for expecting the middle or lower half of its range are the cost of geopolitical tensions and the US investment step-up; the CFO said that without the geopolitical costs the company would be in the mid- to upper end of the range. He put higher energy-linked costs and disruption in Ukraine together at about 1 point of growth in adjusted earnings per share for the year.

Whether the cut pays is not yet settled by the evidence. The release says ZYN gained more than 100 basis points of category share between June and September, by Nielsen's estimate, and ZYN shipments grew last quarter despite a comparison inflated by last year's promotion. But shipments measure what the company sells to the trade, not what consumers buy, and one analyst on the call cited third-party scanner data pointing to volumes down mid-single digits in the quarter. Management has accepted roughly nil US profit for a quarter, and less revenue per pouch after that, in return for the volume growth it expects.